ExLibris header image
SFX Logo
Title: Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage–colony stimulating factor
Source:

Cancer [0008-543X] Baxevanis, Constantin yr:1995


Collapse list of basic services Basic
Full text
Full text available via Wiley Online Library Free Backfiles
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Fabian, I. "Granulocyte-macrophage colony-stimulating factor dependent monocyte-mediated cytotoxicity post-autologous bone marrow transplantation." Leukemia research (1996): 637-643. Link to Full Text for this item Link to SFX for this item
2. Sondel, Paul M D. "A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group." Clinical cancer research 12.6 (2006): 1750-1759. Link to SFX for this item
3. Shusterman, S. "Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study." Journal of clinical oncology 28.33 (2010): 4969-75. Link to SFX for this item
4. Ozkaynak, M F F. "Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer." Journal of clinical oncology 18.24 (2000): 4077-85. Link to SFX for this item
5. Daz-Prez, Antonio A. "KIR-HLA receptor-ligand mismatch associated with a graft-versus-tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors." Pediatric blood & cancer 53.1 (2009): 120-124. Link to Full Text for this item Link to SFX for this item
6. Pinkerton, C R R. "Treatment strategies for metastatic Ewing's sarcoma." European journal of cancer 37.11 (2001): 1338-44. Link to Full Text for this item Link to SFX for this item
7. Seeger, Robert C M. "Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study." Journal of clinical oncology 24.3 (2005): 500-6. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced